The U.S. can immediately resume use of Johnson & Johnson’s COVID-19 vaccine ending a 10-day pause to investigate link to potentially deadly blood clots.
The U.S. can immediately resume use of Johnson & Johnson’s COVID-19 vaccine ending a 10-day pause to investigate link to potentially deadly blood clots.
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.
